Clinical trials
Coronary artery disease clinical trials
Narrowing of the arteries that supply blood to the heart. We’re tracking 731 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06313645Recruiting
Blood vessel aging and heart attack risk study
This study looks at how blood vessel aging relates to the type of fatty buildup in your arteries that can cause heart attacks. If you've had a recent heart attack, chest pain (angina), or minor artery disease and do not have advanced heart failure, kidney failure, active cancer, or prior bypass surgery, you may be able to join.
Milan, LombardyAges 18–75 - NCT06445608Recruiting
Study of a heart pump for high-risk angioplasty
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
Chandler, ArizonaAges 18–90 - NCT06453538Recruiting
Sleep and breathing in bypass surgery patients
This study looks at how well patients sleep and if they have breathing problems during sleep before and after heart bypass surgery. It may help understand how sleep affects recovery.
TurkuAges 18–90 - NCT06489080Recruiting
Heart attack follow-up study on survival and health
This study looks at how people with heart attacks do over time, including their survival and any heart-related events. It helps doctors understand more about the condition and how to improve care.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06509893RecruitingPhase 4
Ticagrelor alone after stent placement
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
Shiraz, FarsAges 20–80 - NCT06535854Recruiting
Prevail Stent Study for Heart Disease
This study tests a new type of stent for people with narrowed heart arteries causing chest pain or a recent mild heart attack. It aims to see if the stent is safe and effective in improving blood flow without serious side effects.
Birmingham, AlabamaAges 18 years+ - NCT06577896Recruiting
Onyx stent safety and effectiveness in older adults
This study looks at how well a specific brand of heart stent (Onyx) works in people 75 and older who have narrowed heart arteries. If you've already received an Onyx stent, the study will check its safety and effectiveness over time.
Yangsan, Gyeongsangnam-doAges 75–100 - NCT06620523RecruitingPhase 2
Preventing kidney injury after heart bypass surgery
This trial tests whether combining two natural supplements (CoQ10 and glutathione) can protect your kidneys during heart bypass surgery. It may help prevent acute kidney injury, a common complication after these procedures.
Washington D.C., District of ColumbiaAges 18–70 - NCT06691191RecruitingPhase 4
Switching to a single blood thinner after heart stent
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
Jacksonville, FloridaAges 18–75 - NCT06705023RecruitingPhase 2
Fat-derived cell therapy for heart failure
This study tests whether taking a small amount of your own belly fat (through liposuction), processing it, and injecting the cells back into your heart can improve heart function in people with chronic heart failure due to blocked arteries. The trial is for patients whose heart pumps weakly (ejection fraction of 40% or less) and who are already on standard medications.
AstanaAges 21–80 - NCT06790836Recruiting
CT scan vs. invasive test for heart artery blood flow
This study looks at how well a special CT scan (FFR CT) matches the results of a more invasive wire test (invasive FFR) for measuring blood flow in heart arteries. It may help doctors use CT scans more confidently instead of always needing the invasive procedure.
Birmingham, West MidlandsAges 18 years+ - NCT06820970Recruiting
Combined therapy for heart artery blockages that weren't fully opened
This trial tests if combining a new heart procedure with a special type of therapy called mindfulness therapy can help prevent heart problems in people with coronary artery disease that could not be fully fixed with stents or surgery.
Zhengzhou, HenanAges 18 years+ - NCT06821191RecruitingPhase 4
Safer blood thinner plan after heart stent
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
Jacksonville, FloridaAges 18 years+ - NCT06839755Recruiting
Stress echo's positive value in heart health
This study looks at how well a stress echocardiogram (heart ultrasound during exercise or medication) predicts future health in people who have some sign of reduced blood flow to the heart. The goal is to confirm that a positive stress echo is a good sign for guiding next steps.
Athens, AtticaAges 18–100 - NCT06908499Recruiting
Long-term follow-up of a stent study for chronic total occlusions
This study looks at the long-term (10-year) outcomes of a specific stenting technique for patients with a chronic total occlusion (a complete blockage that has been there for at least 3 months) in a major heart artery. It aims to see how well the procedure works over time.
Pune, MaharashtraAges 19 years+ - NCT06993636Recruiting
Study of rivaroxaban in Chinese children with large heart artery bulges
This trial is testing the drug rivaroxaban in children aged 2 to 17 who have large bulges (aneurysms) in their heart arteries after Kawasaki disease. It aims to see how the drug works in the body to prevent blood clots.
Shanghai, Shanghai MunicipalityAges 2–18 - NCT06995183Recruiting
Heart CT scan for relatives with high or low Lp(a)
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
Amsterdam, North HollandAges 50 years+ - NCT07035106Recruiting
Using wearables to track recovery after ICU
This study tests if a wearable device and health summaries can help people recover after a stay in the intensive care unit (ICU). It is for people who have diabetes or heart problems and left the ICU within the last 2 years.
ViennaAges 18–65 - NCT07039812Recruiting
Virtual Reality for Pain During Dressing Changes After Heart Surgery
This study tests if using virtual reality or an eye mask during wound dressing changes can help reduce pain and anxiety after coronary artery bypass surgery. It aims to find a drug-free way to make dressing changes more comfortable.
Istanbul, MarmaraAges 18–65 - NCT07048808RecruitingPhase 2
Gene therapy for chronic chest pain
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
Cincinnati, OhioAges 18–85 - NCT07169201Recruiting
CT scan for heart in people with diabetes or heart disease
This study uses a special CT scan to look at your heart more closely. It may help people with known or suspected heart problems or type 2 diabetes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07198529Recruiting
Short blood thinners after stenting for stable angina
This trial is testing a way to shorten the time you need to take blood thinners after getting a specific type of heart stent. It uses a special camera (OCT) inside the artery to help decide if stents are placed well enough to allow less time on dual antiplatelet therapy.
Seoul, Gurodong-ro, Guro-guAges 19 years+ - NCT07225842RecruitingPhase 4
Bridging with Cangrelor: A study on pre-procedure blood thinner use
This study looks at how well a certain blood thinner (cangrelor) works when used as a 'bridge' before surgery or another procedure. It is for people who already need to be on this medicine for a short time.
Jacksonville, FloridaAges 18 years+ - NCT07292909RecruitingPhase 4
Effect of Empagliflozin on Inflammation for Coronary Patients
This trial tests if the diabetes drug empagliflozin can help reduce inflammation in people with stable coronary artery disease who are planning to have a stent placed. It may offer a new way to protect heart health.
Beirut, BeirutAges 18 years+
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coronary artery disease?
- Yes. Clin2 currently lists 731 recruiting coronary artery disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coronary artery disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coronary artery disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.